Trademark Alertz ®
Search
Trademark
Owner
Trademark: T'SUMOYLE 1972382
Word
T'SUMOYLE
ID
1972382
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
18 September 2018
Registration Date
18 September 2018
Renewal Date
18 September 2028
Owner(s)
Clinuvel (UK) Ltd
Service
Goods and Services:
Class 3
:
Skin care preparations
;
cosmetic preparations for skin care
;
cosmetic preparations for skin care, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide
;
cosmetic oils
;
skin creams (cosmetic)
;
skin care creams (cosmetic), lotions (cosmetic) and oils (cosmetic)
;
wrinkle removing skin care preparations
;
sunscreens
;
waterproof sunscreen
;
sunscreen preparations
;
sunscreen creams and lotions
;
cosmetics for protecting the skin from sunburn
;
sunblock
;
sun barriers (cosmetics)
;
sun creams
;
cosmetic preparations for protecting the skin from the sun's rays
;
sun care lotions
;
compounds for skin care after exposure to the sun's rays
;
after-sun milks, creams, lotions and moisturizers
;
sun bronzers
;
sun-tanning preparations
;
cosmetics for tanning the skin including preparations for tanning without sunlight, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide
;
self-tanning preparations (cosmetic)
;
self -tanning creams (cosmetic) and lotions (cosmetic)
;
suntan creams, lotions, oils and gels
;
skin rejuvenation preparations
;
skin rejuvenation products with and without analogues of alpha-melanocyte stimulating hormone (alpha-MSH)
;
antiaging skincare preparations
;
antiaging creams, lotions, moisturizers, gels, balms and serums
;
cleansing creams, lotions, milks, foam, gels and masks.
Class 5
:
Pharmaceuticals
;
pharmaceutical drugs
;
pharmaceutical preparations
;
pharmaceutical preparations, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide
;
sun tanning preparations for pharmaceutical purposes, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide
;
pharmaceutical preparations for skin care
;
pharmaceutical preparations for treating skin disorders
;
dermatological preparations
;
dermatological pharmaceutical substances
;
dermatological pharmaceutical products
;
medicinal creams for the protection of the skin
;
skin care creams for medical use
;
skin care preparations for medical use
;
medicated skin creams and lotions
;
medicated creams for application after exposure to the sun
;
pharmaceutical skin lotions
;
preparations for cleansing the skin for medical use
;
chemical and biological preparations, substances, reagents and compounds for the delivery and storage of pharmaceuticals which are preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide.